REFERENCES
- Briggner L. E., Buckton G., Bystrom K., Darcy P. The use of isothermal microcalorimetry in the study of changes in crystallinity induced during the processing of powders. Int. J. Pharm. 1994; 105: 125–135
- Brodka-Pfeiffer K., Langguth P., Graß P., Häusler H. Influence of mechanical activation on the physical stability of salbutamol sulphate. Eur. J. Pharm. Biopharm. 2003; 56: 393–400
- Buckton G., Darcy P. The use of gravimetric studies to assess the degree of crystallinity of predominantly crystalline powders. Int. J. Pharm. 1995; 123: 265–271
- Buckton G., Darcy P. Assessment of disorder in crystalline powders – a review of analytical techniques and their application. Int. J. Pharm. 1999; 179: 141–158
- Chawla A., Taylor K. M. G., Newton J. M., Johnson M. C. R. Production of spray dried salbutamol sulphate for use in dry powder aerosol formulation. Int. J. Pharm. 1994; 108: 233–240
- Elamin A. A., Ahlneck C., Alderborn G., Nyström C. Increased metastable solubility of milled griseofulvin, depending on the formation of a disordered surface structure. Int. J. Pharm. 1994; 111: 159–170
- Mackin L., Zanon R., Min Park J., Foster K., Opalenik H., Demonte M. Quantification of low levels (<10%) of amorphous content in micronised active batches using dynamic vapour sorption and isothermal microcalorimetry. Int. J. Pharm. 2002; 231: 227–236
- Mikhail S. A., Turcotte A. M. The determination of low levels of crystalline silica in slag and silica fume. Thermochimica Acta 1997; 292: 111–114
- Saleki-Gerhardt A., Ahlneck C., Zografi G. Assessment of disorder in crystalline solids. Int. J. Pharm. 1994; 101: 237–247
- Ward G. H., Schultz R. K. Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability. Pharm. Res. 1995; 12: 773–779